Jump to navigation
For US Residents Only
With an unwavering commitment to patients with rare diseases, rEVO Biologics is moving healthcare forward.
rEVO Biologics is a rare disease company delivering on the promise of innovative therapies.
Through groundbreaking technology, rEVO Biologics is changing the way rare diseases are treated.
rEVO Biologics is focused on the development and commercialization of innovative therapeutics for rare diseases.
Learn more about ATryn, the world's only recombinant antithrombin.
The rEVO Biologics pipeline is focused on meeting the needs of under-served patient populations through innovative recombinant protein therapies.
Stay up to date on rEVO Biologics, Inc. news, events, products and technology.